Human medicines European public assessment report (EPAR): VacPertagen, pertussis vaccine (recombinant, acellular, component, adsorbed), Date of authorisation: 09/01/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Lantus, insulin glargine, Date of authorisation: 09/06/2000, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Insuman, insulin human, Date of authorisation: 21/02/1997, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Imatinib Teva, imatinib, Date of authorisation: 07/01/2013, Revision: 21, Status: Authorised

Variations not requiring assessment (veterinary medicines)

Transferring a veterinary marketing authorisation

Product-information requirements for veterinary medicines

New guidance on the conduct of clinical trials during public health emergencies in the EU

Human medicines European public assessment report (EPAR): Simponi, golimumab, Date of authorisation: 01/10/2009, Revision: 54, Status: Authorised

Agenda - Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026